<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6</volume><submitter>Chen J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Shrimp allergy (SA) represents a significant public health concern, yet its overall prevalence remains unclear.&lt;h4>Method&lt;/h4>A systematic search of PubMed, Web of Science, and Embase through September 30, 2024 identified 40 studies that reported SA prevalence using self-reported symptoms, physician diagnosis, skin prick tests, specific IgE, or food challenge tests.&lt;h4>Results&lt;/h4>The pooled prevalence was estimated at 1.90% for self-reported symptomatic SA and 1.94% for self-reported physician-diagnosed SA, while testing via skin prick or specific IgE yielded a prevalence of 2.76%. Notably, symptomatic testing showed a lower prevalence of 0.43%, and food challenge tests confirmed a prevalence of 0.50%. Considerable heterogeneity was observed across studies, with prevale</pubmed_abstract><journal>Frontiers in allergy</journal><pagination>1635274</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12434110</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prevalence of shrimp allergy: a meta-analysis based on different diagnostic methods.</pubmed_title><pmcid>PMC12434110</pmcid><pubmed_authors>Qu C</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Ying Y</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prevalence of shrimp allergy: a meta-analysis based on different diagnostic methods.</name><description>&lt;h4>Background&lt;/h4>Shrimp allergy (SA) represents a significant public health concern, yet its overall prevalence remains unclear.&lt;h4>Method&lt;/h4>A systematic search of PubMed, Web of Science, and Embase through September 30, 2024 identified 40 studies that reported SA prevalence using self-reported symptoms, physician diagnosis, skin prick tests, specific IgE, or food challenge tests.&lt;h4>Results&lt;/h4>The pooled prevalence was estimated at 1.90% for self-reported symptomatic SA and 1.94% for self-reported physician-diagnosed SA, while testing via skin prick or specific IgE yielded a prevalence of 2.76%. Notably, symptomatic testing showed a lower prevalence of 0.43%, and food challenge tests confirmed a prevalence of 0.50%. Considerable heterogeneity was observed across studies, with prevale</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-02T05:49:35.491Z</modification><creation>2026-04-14T03:14:23.733Z</creation></dates><accession>S-EPMC12434110</accession><cross_references><pubmed>40958988</pubmed><doi>10.3389/falgy.2025.1635274</doi></cross_references></HashMap>